Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study

Fenofibrate lowers triglycerides (TG) and raises high density lipoprotein cholesterol (HDLc) in dyslipidemic individuals. Several studies have shown genetic variability in lipid responses to fenofibrate treatment. It is, however, not known whether epigenetic patterns are also correlated with the cha...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Genet
Huvudupphovsmän: Das, Mithun, Irvin, M. Ryan, Sha, Jin, Aslibekyan, Stella, Hidalgo, Bertha, Perry, Rodney T., Zhi, Degui, Tiwari, Hemant K., Absher, Devin, Ordovas, Jose M., Arnett, Donna K.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2015
Ämnen:
Pharmacology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4586504/
https://ncbi.nlm.nih.gov/pubmed/26483836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2015.00304
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk